Jeena Sikho Lifecare Limited (BOM:544476)
505.20
-1.50 (-0.30%)
At close: Aug 21, 2026
Jeena Sikho Lifecare Revenue
Jeena Sikho Lifecare had revenue of 2.24B INR in the quarter ending June 30, 2026, with 28.76% growth. This brings the company's revenue in the last twelve months to 8.51B, up 58.77% year-over-year. In the fiscal year ending March 31, 2026, Jeena Sikho Lifecare had annual revenue of 8.01B with 70.84% growth.
Revenue (ttm)
8.51B
Revenue Growth
+58.77%
P/S Ratio
7.38
Revenue / Employee
2.26M
Employees
3,764
Market Cap
62.82B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.01B | 3.32B | 70.84% |
| Mar 31, 2025 | 4.69B | 1.45B | 44.59% |
| Mar 31, 2024 | 3.24B | 1.21B | 59.10% |
| Mar 31, 2023 | 2.04B | 573.42M | 39.13% |
| Mar 31, 2022 | 1.47B | 107.46M | 7.91% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viyash Scientific | 35.75B |
| Unichem Laboratories | 23.08B |
| FDC Limited | 21.90B |
| Morepen Laboratories | 19.51B |
| Sanofi India | 18.05B |
| CORONA Remedies | 14.79B |
| Procter & Gamble Health | 14.33B |
| Bliss GVS Pharma | 10.05B |